ACC Update: Rivaroxaban Reduces Venous Thromboembolism Recurrence Compared with Aspirin savita thakur thakur20 March 2017 5:04 PM ISTWASHINGTON: In patients at elevated risk for a recurrence of potentially life-threatening blood clots, a low dose of the oral blood-thinning...
Many Patients on blood-thinning drugs for atrial fibrillation not getting right dose, finds Mayo Study Ruby khatun khatun7 Jun 2017 10:29 AM ISTAlmost 1 in 6 of the millions of Americans on the new blood-thinning medications for atrial fibrillation, a common heart condition characterized by an...
Combination therapy works best for prevention of complications in cardiac patients : NEJM Anjali Nimesh Nimesh28 Aug 2017 11:00 AM ISTA major international study has found that the combination of two drugs rivaroxaban and aspirin is superior to aspirin alone in preventing further...
Add Rivaroxaban to aspirin for Stable CAD and PAD: COMPASS Trial Dr. Prem Aggarwal5 Oct 2017 10:30 AM ISTAtherosclerosis now is more considered as athero-thrombosis and Aspirin is the single most used preventive treatment but offers only a 19% relative...
Blood-thinning drugs reduce risk of dementia by up to 48% Anjali Nimesh Nimesh1 Nov 2017 7:20 PM ISTBlood-thinning drugs could protect against dementia and stroke in people with an irregular heartbeat, research suggests.A study found that patients...
Rivaroxaban approved for long term VTE Protection by FDA Dr. Kamal Kant Kohli Kohli31 Oct 2017 7:25 PM ISTRivaroxaban in a dose of 10 mg once daily has been cleared by the US Food and Drug Administration (FDA) for combating the ongoing risk of recurrent...
Apixaban rated most efficient at treating atrial fibrillation in a Meta Analysis Dr. Kamal Kant Kohli Kohli2 Dec 2017 7:22 PM ISTIn a meta-analysis comparing the drugs with each other and with warfarin, among direct-acting oral anticoagulants (DOACs) Apixaban was rated most...
New ACC Guidelines for management of bleeding in patients on oral anticoagulants Dr. Kamal Kant Kohli Kohli17 Dec 2017 7:02 PM ISTThe American College of Cardiology (ACC) has released an expert consensus decision pathway on management of bleeding in patients on oral...
Andexanet alfa reverses complication of bleeding associated with DOACs Dr. Kamal Kant Kohli Kohli21 Feb 2018 7:20 PM ISTVery recently developed direct oral anticoagulants (DOACs) Rivaroxaban, apixaban, and edoxaban are direct inhibitors of FXa approved for the...
Aspirin NOT Inferior to Rivaroxaban for VTE prevention after arthroplasty-EPCAT II Trial Dr. Kamal Kant Kohli Kohli25 Feb 2018 8:00 PM ISTNo data is available regarding comparison of aspirin with direct oral anticoagulants in the prevention of venous thromboembolism after total hip or...
FDA Grants Approval to Andexanet Alfa for Rapid NOAC Reversal Medha Baranwal Baranwal6 May 2018 7:30 PM ISTThe U.S. Food and Drug Administration (FDA) has granted approval to andexanet alfa (Andexxa) as the first antidote indicated for the patients treated...
Rivaroxaban -New treatment for DVT in cancer patients Vinay Singh singh13 May 2018 7:20 PM ISTCurrent international guidelines recommend cancer patients are injected with an anticoagulant (a low molecular weight heparin) to treat and prevent...
